| # | Drug | Count |
|---|---|---|
| 0 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | 2 |
| 1 | AZATHIOPRINE | 1 |
| 2 | DUPILUMAB | 1 |
| 3 | ESCITALOPRAM | 1 |
| 4 | ESCITALOPRAM OXALATE | 1 |
| 5 | ESCITSLOPRAM | 1 |
| 6 | INFLIXIMAB | 1 |
| 7 | METHOTREXATE | 1 |
| 8 | METHOTREXATE SODIUM | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | 2 | 0.0002 |
| 1 | AZATHIOPRINE | 1 | 0.0000 |
| 2 | ESCITALOPRAM | 1 | 0.0000 |
| 3 | INFLIXIMAB | 1 | 0.0000 |
| 4 | METHOTREXATE SODIUM | 1 | 0.0000 |
| 5 | DUPILUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytochrome P450 3A Inhibitor [EPC] | 2 | 0.0000 |
| 1 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Interleukin-4 Receptor alpha Antagonist [EPC] | 1 | 0.0000 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 1 | 0.0000 |